Resumen
El entendimiento de las caracteristicas clínicas del espectro de trastornos de Neuromielitis óptica (NMOSD) con mielitis parcial y neuritis óptica típica ha ampliado el diagnóstico en casos atípicos. Presentamos el caso de una mujer de 47 años que debuta con neuritis óptica atípica y mielitis parcial. Resonancia magnética cerebral y órbitas con realce de nervio óptico, quiasma óptico y tracto óptico derecho, de columna cervical y torácica contrastada con mielitis parcial a nivel C4 y T2. Fue tratada con bolos de metilprednisolona y plasmaferesis, con buena respuesta clínica. Se realizó anticuerpos aquaporina 4 sérico positivos.
Citas
Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177-89.
Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica Wingerchuk, D.M. et al., 2007. The spectrum of neuromyelitis optica. , 6(September). 2007;6(September).
Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aqua-porin-4 water channel. J Exp Med [Internet]. 2005;202(4):473-7. Available from: http://www.jem.org/lookup/doi/10.1084/jem.20050304
Papadopoulos MC, Verkman AS. Aquaporin 4 and neuromyelitis optica. Lancet Neurol [Internet]. 2012;11(6):535-44. Available from: http://dx.doi.org/10.1016/S1474-4422(12)70133-3
Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C, et al. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation [Internet]. 2012;9(1):14. Available from: http://www.jneuroinflammation.com/con-tent/9/1/14
Kim SH, Kim W Li XF, Jung IJ, Kim HJ. Clinical spectrum of CNS aquaporin-4 autoimmunity. Neurology. 2012;78(15):1179-85.
Kitley J, Leite MI, Nakashima I, Waters P, McNeillis B, Brown R, et al. Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. Brain. 2012;135(6):1834-49.
Hyun JW, Kim SH, Jeong IH, Lee SH, Kim HJ. Bright spotty lesions on the spinal cord: An additional MRI indicator of neuromyelitis optica spectrum disorder? J Neurol Neurosurg Psychiatry. 2015;86(11):1280-2.
Sepúlveda M, Armangué ?, Sola-Valls N, Arrambide G, Meca-Lallana JE, Oreja-Guevara C, et al. Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus. Neurol Neuroimmunol NeuroInflammation. 2016;3(3):1-9.
Flanagan EP, Cabre P, Weinshenker BG, Sauver JS, Jacobson DJ, Majed M, et al. Epidemiology of aquaporin-4 autoim-munity and neuromyelitis optica spectrum. Ann Neurol. 2016;79(5):775-83.
Lycklama G, Thompson A, Filippi M, Miller D, Polman C, Fazekas F, et al. Spinal-cord MRI in multiple sclerosis. Lancet Neurol. 2003;2(9):555-62.
Hardy TA, Reddel SW, Barnett MH, Palace J, Lucchinetti CF, Weinshenker BG. Atypical inflammatory demyelinating syndromes of the CNS. Lancet Neurol. 2016;15(9):967-81.
Confavreux C, Vukusic S. Natural history of multiple sclerosis: A unifying concept. Brain. 2006;129(3):606-16.
Bourre B, Zéphir H, Ongagna JC, Cordonnier C, Collongues N, Debette S, et al. Longterm follow-up of acute partial transverse myelitis. Arch Neurol. 2012;69(3):357-62.
Flanagan EP, Weinshenker BG, Krecke KN, Lennon VA, Lucchinetti CF, McKeon A, et al. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders. JAMA Neurol. 2015;72(1):81-7.
Huh S-Y, Kim S-H, Hyun J-W, Jeong IH, Park MS, Lee S-H, et al. Short segment myelitis as a first manifestation of neu-romyelitis optica spectrum disorders. Mult Scler J [Internet]. 2017 Mar 9;23(3):413-9. Available from: http://132.248.9.34/hevila/Medunab/2010/vol13/no2/6.pdf
T.F. Scott; E.M. Frohman; J. De Seze; G.S. Gronseth; B. G. Weinshenker. Evidence-based guideline: Clinical evaluation and treatment of transverse myelitis. Neurology. 2011;77(December, 7):2128-34.
Hyun JW, Jeong IH, Joung A, Kim SH, Kim HJ. Evaluation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorder. Neurology. 2016;86(19):1772-9.
De Carvalho Jennings Pereira WL, Reiche EMV, Kallaur AP, Kaimen-Maciel DR. Epidemiological, clinical, and immunological characteristics of neuromyelitis optica: A review. J Neurol Sci [Internet]. 2015;355(1-2):7-17. Available from: http://dx.doi.org/10.1016/j.jns.2015.05.034
Etemadifar M, Nasr Z, Khalili B, Taherioun M, Vosoughi R. Epidemiology of Neuromyelitis Optica in the World: A Systematic Review and Meta-Analysis. Mult Scler Int [Internet]. 2015;2015:1-8. Available from: http://www.hindawi.com/journals/msi/2015/174720/
Asgari N, Lillevang ST, Skejoe HPB, Falah M, Stenager E, Kyvik KO. A population-based study of neuromyelitis optica in Caucasians. Neurology. 2011;76(18):1589-95.
Pandit L, Asgari N, Apiwattanakul M, Palace J, Paul F, Leite MI, et al. Demographic and clinical features of neuromyelitis optica: A review. Mult Scler J. 2015;21(7):845-53.
Cabre P, Gonzalez-Quevedo A, Lannuzel A, Bonnan M, Merle H, Olindo S, et al. Epidémiologie Descriptive De La Neuromyélite Optique Dans Le Bassin Caraïbéen. Rev Neurol (Paris). 2009;165(8-9):676-83.
Rivera VM, Cabrera JA, Mirsattari S, Power C. Aboriginals with multiple sclerosis: HLA types and predominance of neuromyelitis optica. Neurology [Internet]. 2001 Sep 11;57(5):937-8. Available from: http://www.neurology.org/cgi/doi/10.1212/WNL.57.5.937
Rivera JF, Kurtzke JF, Booth VJA, Corona T. Characteristics of Devic's disease (neuromyelitis optica) in Mexico. J Neurol [Internet]. 2008 May 19;255(5):710-5. Available from: http://link.springer.com/10.1007/s00415-008-0781-2
Sellner J, Hemmer B, Mühlau M. The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes. J Autoimmun. 2010;34(4):371-9.
Bennett JL, Lam C, Kalluri SR, Saikali P, Bautista K, Dupree C, et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol. 2009;66(5):617-29.
Popescu B, Lennon V, Parisi J. Neuromyelitis optica unique area postrema lesions. Neurology [Internet]. 2011;(76):1229-37. Available from: http://www.neurology.org/content/76/14/1229.short
Ghezzi A, Bergamaschi R, Martinelli V, Trojano M, Tola MR, Merelli E, et al. Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica. J Neurol. 2004;251(1):47-52.
Verkman AS. Aquaporins in Clinical Medicine. Annu Rev Med [Internet]. 2012;63(1):303-16. Available from: http://www.annualreviews.org/doi/10.1146/annurev-med-043010-193843
Jacob A, McKeon A, Nakashima I, Sato DK, Elsone L, Fujihara K, et al. Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders. J Neurol Neurosurg Psychiatry. 2013;84(8):922-30.
Di Pauli F, Mader S, Rostasy K, Schanda K, Bajer-Kornek B, Ehling R, et al. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases. Clin Immunol [Internet]. 2011;138(3):247-54. Available from: http://dx.doi.org/10.1016/j.clim.2010.11.013
Akman-Demir G, Tüzün E, Waters P, Içõz S, Kürtüncü M, Jarius S, et al. Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients. J Neurol. 2011;258(3):464-70.
Wang H, Dai Y, Qiu W, Zhong X, Wu A, Wang Y, et al. HLA-DPB1*0501 is associated with susceptibility to anti-aquaporin-4 antibodies positive neuromyelitis optica in Southern Han Chinese. J Neuroimmunol [Internet]. 2011;233(1-2):181-4. Available from: http://dx.doi.org/10.1016/j.jneuroim.2010.11.004
Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol. 2006;59(3):566-9.
Cabre P, Heinzlef O, Merle H, Buisson GG, Bera O, Bellance R, et al. MS and neuromyelitis optica in Martinique (French West Indies). Neurology. 2001;56(4):507-14.
Uzawa A, Mori M, Kuwabara S. Neuromyelitis optica: Concept, immunology and treatment. J Clin Neurosci [Internet]. 2014;21(1):12-21. Available from: http://dx.doi.org/10.1016/j.jocn.2012.12.022
Lucchinetti CF, Guo Y, Popescu BFG, Fujihara K, Itoyama Y, Misu ?. The pathology of an autoimmune astrocytopathy: Lessons learned from neuromyelitis optica. Brain Pathol. 2014;24(1):83-97.
Jarius S, Wildemann B, Paul F. Neuromyelitis optica: Clinical features, immunopathogenesis and treatment. Clin Exp Immunol. 2014;176(2):149-64.
Dumrikarnlert C, Siritho S, Chulapimphan P, Ngamsombat C, Satukijchai C, Prayoonwiwat N. The characteristics of spinal imaging in different types of demyelinating diseases. J Neurol Sci [Internet]. 2017;372(January 2015):138-43. Available from: http://dx.doi.org/10.1016/j.jns.2016.11.035
Jarius S, Paul F, Franciotta D, Ruprecht K, Ringelstein M, Bergamaschi R, et al. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures. J Neurol Sci [Internet]. 2011;306(1-2):82-90. Available from: http://dx.doi.org/10.1016/j.jns.2011.03.038
Seewann A, Enzinger C, Filippi M, Barkhof F, Rovira A, Gass A, et al. MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain: A review of reported findings. J Neurol. 2008;255(1):1-10.
Eckstein C, Saidha S, Levy M. A differential diagnosis of central nervous system demyelination: Beyond multiple sclerosis. J Neurol. 2012;259(5):801-16.
Barreras P, Fitzgerald KC, Mealy MA, Jimenez JA, Becker D, Newsome SD, et al. Clinical biomarkers differentiate myelitis from vascular and other causes of myelopathy. Neurology [Internet]. 2017;0:10.1212/WNL.0000000000004765. Available from: http://www.neurology.org/lookup/doi/10.1212/WNL.0000000000004765
Hu H, You X, Ye J. Short transverse myelitis in Chinese patients with neuromyelitis optica spectrum disorders. Mult Scler Relat Disord [Internet]. 2018;21:78-83. Available from: https://doi.org/10.1016/j.msard.2018.02.022
Carnero Contentti E, Hryb JP, Morales S, Gomez A, Chiganer E, Di Pace JL, et al. Longitudinally extensive transverse myelitis immune-mediated in aquaporin-4 antibody negative patients: Disease heterogeneity. J Neurol Sci [Internet]. 2017;373:134-7. Available from: http://dx.doi.org/10.1016/j.jns.2016.12.033
Borisow N, Mori M, Kuwabara S, Scheel M, Paul F. Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis. Front Neurol [Internet]. 2018;9(October):1-15. Available from: https://www.frontiersin.org/article/10.3389/fneur.2018.00888/full
Bouzar M, Daoudi S, Hattab S, Bouzar AA, Deiva K, Wildemann B, et al. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aqua-porin-4: Clinical and paraclinical characteristics in Algerian patients. J Neurol Sci [Internet]. 2017;381:240-4. Available from: http://dx.doi.org/10.1016/j.jns.2017.08.3254
Akaishi ?, Nakashima I, Sato DK, Takahashi ?, Fujihara K. Neuromyelitis Optica Spectrum Disorders. Neuroimaging Clin N Am [Internet]. 2017 May;27(2):251-65. Available from: http://dx.doi.org/10.1016/j.nic.2016.12.010
Zhang J, Liu F, Wang Y, Yang Y, Huang Y, Zhao H, et al. Aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder with recurrent short partial transverse myelitis and favorable prognosis: Two new cases. Mult Scler J [Internet]. 2017 Dec 5;23(14):1950-4. Available from: http://132.248.9.34/hevila/Medunab/2010/vol13/no2/6.pdf
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.